Cancer-associated mutations often lead to perturbed cellular energy
metabolism and accumulation of potentially harmful oncometabolites. One example
is the chiral molecule 2-hydroxyglutarate (2HG); its two stereoisomers (D- and
L-2HG) have been found with abnormally high concentrations in tumors featuring
anomalous metabolic pathways. 2HG has been demonstrated to competitively inhibit
several α-ketoglutarate (αKG)- and non-heme iron-dependent
dioxygenases, including some of the AlkB family DNA repair enzymes, such as
ALKBH2 and ALKBH3. However, previous studies have only provided the
IC50 values of D-2HG on the enzymes and the results have not been
correlated to physiologically relevant concentrations of 2HG and αKG in
cancer cells. In this work, we carried out detailed kinetic analyses of DNA
repair reactions catalyzed by ALKBH2, ALKBH3 and the bacterial AlkB in the
presence of D- and L-2HG in both double and single stranded DNA contexts. We
determined kinetic parameters of inhibition, including kcat,
KM, and Ki. We also correlated the relative
concentrations of 2HG and αKG previously measured in tumor cells with
the inhibitory effect of 2HG on the AlkB family enzymes. Both D- and L-2HG
significantly inhibited the human DNA repair enzymes ALKBH2 and ALKBH3 under
pathologically relevant concentrations (73–88% for D-2HG and
31–58% for L-2HG inhibition). This work provides a new
perspective that the elevation of either D- or L-2HG in cancer cells may
contribute to an increased mutation rate by inhibiting the DNA repair carried
out by the AlkB family enzymes and thus exacerbate the genesis and progression
of tumors.